Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 1 of 1 entries
Sorted by: Best Match Show Resources per page
Dendritic Cell Vaccines for Cancer Immunotherapy: The Role of Human Conventional Type 1 Dendritic Cells.

Pharmaceutics

Calmeiro J, Carrascal MA, Tavares AR, Ferreira DA, Gomes C, Falcão A, Cruz MT, Neves BM.
PMID: 32075343
Pharmaceutics. 2020 Feb 15;12(2). doi: 10.3390/pharmaceutics12020158.

Throughout the last decades, dendritic cell (DC)-based anti-tumor vaccines have proven to be a safe therapeutic approach, although with inconsistent clinical results. The functional limitations of ex vivo monocyte-derived dendritic cells (MoDCs) commonly used in these therapies are one...

Cite
Calmeiro J, Carrascal MA, Tavares AR, et al. Dendritic Cell Vaccines for Cancer Immunotherapy: The Role of Human Conventional Type 1 Dendritic Cells. Pharmaceutics. 2020;12(2)doi: 10.3390/pharmaceutics12020158.
Calmeiro, J., Carrascal, M. A., Tavares, A. R., Ferreira, D. A., Gomes, C., Falcão, A., Cruz, M. T., & Neves, B. M. (2020). Dendritic Cell Vaccines for Cancer Immunotherapy: The Role of Human Conventional Type 1 Dendritic Cells. Pharmaceutics, 12(2), . https://doi.org/10.3390/pharmaceutics12020158
Calmeiro, João, et al. "Dendritic Cell Vaccines for Cancer Immunotherapy: The Role of Human Conventional Type 1 Dendritic Cells." Pharmaceutics vol. 12,2 (2020). doi: https://doi.org/10.3390/pharmaceutics12020158
Calmeiro J, Carrascal MA, Tavares AR, Ferreira DA, Gomes C, Falcão A, Cruz MT, Neves BM. Dendritic Cell Vaccines for Cancer Immunotherapy: The Role of Human Conventional Type 1 Dendritic Cells. Pharmaceutics. 2020 Feb 15;12(2). doi: 10.3390/pharmaceutics12020158. PMID: 32075343; PMCID: PMC7076373.
Copy Download .nbib Format: NLM
Showing 1 to 1 of 1 entries